Takeda Pharmaceutical Co Ltd
TAK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395064
In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 19 sales; 379 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; no superinvestor holds it.
Other share classesTKPHF
Q3 2022 vs. Q2 2022
How the institutions holding Takeda Pharmaceutical Co Ltd changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 283 | 9 | 276 | +2 |
| Shares | 57.0M | 100.4K | 63.9M | +7.00M (+12.3%) |
| Value | $800.0M | $1.41M | $828.9M | +$30.4M (+3.8%) |
9 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (35)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (33)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (9)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Altium Wealth Management LLC | 34,938 | $491.0K |
| Advisor Partners LLC | 28,129 | $395.0K |
| BFT Financial Group, LLC | 17,944 | $252.0K |
| HighPoint Advisor Group LLC | 14,995 | $214.0K |
| Private Capital Group, LLC | 1,896 | $27.0K |
| Brewin Dolphin Ltd | 1,027 | $14.0K |
| Emerson Wealth Management, LLC | 952 | $13.0K |
| Fieldpoint Private Securities, LLC | 260 | $4.00K |
| Brewin Dolphin Wealth Management Ltd | 300 | $4.00K |